Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Allergy ; 74(12): 2461-2478, 2019 12.
Article in English | MEDLINE | ID: mdl-31228873

ABSTRACT

BACKGROUND: In the house dust mite (HDM) Dermatophagoides pteronyssinus, Der p 1, 2, 5, 7, 21, and 23 have been identified as the most important allergens. The aim of this study was to define hypoallergenic peptides derived from the sequences of the six allergens and to use the peptides and the complete allergens to study antibody, T cell, and cytokine responses in sensitized and nonsensitized subjects. METHODS: IgE reactivity of HDM-allergic and non-HDM-sensitized individuals to 15 HDM allergens was established using ImmunoCAP ISAC technology. Thirty-three peptides covering the sequences of the six HDM allergens were synthesized. Allergens and peptides were tested for IgE and IgG reactivity by ELISA and ImmunoCAP, respectively. Allergenic activity was determined by basophil activation. CD4+ T cell and cytokine responses were determined in PBMC cultures by CFSE dilution and Luminex technology, respectively. RESULTS: House dust mite allergics showed IgE reactivity only to complete allergens, whereas 31 of the 33 peptides lacked relevant IgE reactivity and allergenic activity. IgG antibodies of HDM-allergic and nonsensitized subjects were directed against peptide epitopes and higher allergen-specific IgG levels were found in HDM allergics. PBMC from HDM-allergics produced higher levels of IL-5 whereas non-HDM-sensitized individuals mounted higher levels of IFN-gamma, IL-17, pro-inflammatory cytokines, and IL-10. CONCLUSION: IgG antibodies in HDM-allergic patients recognize peptide epitopes which are different from the epitopes recognized by IgE. This may explain why naturally occurring allergen-specific IgG antibodies do not protect against IgE-mediated allergic inflammation. A mix of hypoallergenic peptides containing T cell epitopes of the most important HDM allergens was identified.


Subject(s)
Allergens/immunology , Epitopes, T-Lymphocyte/immunology , Hypersensitivity/immunology , Peptides/immunology , Pyroglyphidae/immunology , Animals , Antigens, Dermatophagoides/immunology , Arthropod Proteins/immunology , Case-Control Studies , Cysteine Endopeptidases/immunology , Cytokines/metabolism , Enzyme-Linked Immunosorbent Assay , Humans , Immunoglobulin E/immunology , Immunoglobulin G/immunology
2.
J Proteomics ; 166: 19-26, 2017 08 23.
Article in English | MEDLINE | ID: mdl-28687424

ABSTRACT

Component-resolved diagnosis (CRD) of IgE-mediated hypersensitivities is challenged by the possibility that single patients are sensitized to components not commercially available to the clinical lab. Here, we studied a patient with positive extract-based diagnosis of house dust mite (HDM) allergy based on routine in vivo (prick test) and in vitro (serum specific IgE) tests, whose serum scored negative for IgE to the three recombinant allergens routinely used in CRD (group 1 allergens, group 2 allergens and tropomyosin). By means of serological proteome analysis via two-dimensional gel electrophoresis combined with immunoblotting and mass spectrometry, paramyosin (group 11 allergen: Der f 11 and Der p 11) was identified as the allergen component recognized by serum IgE from this patient in a raw allergen extract. Nine patients (64%) had IgE to Der p 11 in a group of 14 HDM allergic patients. BIOLOGICAL SIGNIFICANCE: Our results add up to previous reports indicating that paramyosin is a clinically relevant HDM allergen and highlight that it can represent, in some patients, the first sensitizing component of this allergen source. This suggests that, at the moment, the use of allergen extract for the purpose of measuring IgE reactivity cannot be replaced by component resolved diagnosis and that group 11 allergens should be included among allergen components routinely tested in the clinical laboratory.


Subject(s)
Allergens/immunology , Proteome/analysis , Pyroglyphidae/immunology , Tropomyosin/immunology , Adolescent , Adult , Animals , Child , Female , Humans , Hypersensitivity/diagnosis , Immunoglobulin E/blood , Male , Middle Aged , Tropomyosin/blood , Young Adult
3.
J Invest Dermatol ; 135(1): 102-109, 2015 Jan.
Article in English | MEDLINE | ID: mdl-24999597

ABSTRACT

House dust mites (HDMs) belong to the most potent indoor allergen sources worldwide and are associated with allergic manifestations in the respiratory tract and the skin. Here we studied the importance of the high-molecular-weight group 11 allergen from Dermatophagoides pteronyssinus (Der p 11) in HDM allergy. Sequence analysis showed that Der p 11 has high homology to paramyosins from mites, ticks, and other invertebrates. A synthetic gene coding for Der p 11 was expressed in Escherichia coli and rDer p 11 purified to homogeneity as folded, alpha-helical protein as determined by circular dichroism spectroscopy. Using antibodies raised against rDer p 11 and immunogold electron microscopy, the allergen was localized in the muscle beneath the skin of mite bodies but not in feces. IgE reactivity of rDer p 11 was tested with sera from HDM-allergic patients from Europe and Africa in radioallergosorbent test-based dot-blot assays. Interestingly, we found that Der p 11 is a major allergen for patients suffering from atopic dermatitis (AD), whereas it is only a minor allergen for patients suffering from respiratory forms of HDM allergy. Thus, rDer p 11 might be a useful serological marker allergen for the identification of a subgroup of HDM-allergic patients suffering from HDM-associated AD.


Subject(s)
Antigens, Dermatophagoides/genetics , Antigens, Dermatophagoides/immunology , Dermatitis, Atopic/immunology , Dermatophagoides pteronyssinus/genetics , Dermatophagoides pteronyssinus/immunology , Adolescent , Adult , Amino Acid Sequence , Animals , Antibodies/blood , Antibodies/immunology , Antigens, Dermatophagoides/chemistry , Arthropod Proteins , Biomarkers , Child , Circular Dichroism , Dermatitis, Atopic/epidemiology , Female , Humans , Immunoglobulin E/blood , Immunoglobulin E/immunology , Male , Molecular Sequence Data , Protein Structure, Secondary , Seroepidemiologic Studies , Tropomyosin/chemistry , Tropomyosin/genetics , Tropomyosin/immunology , Young Adult
4.
J Immunol ; 192(10): 4867-75, 2014 May 15.
Article in English | MEDLINE | ID: mdl-24733847

ABSTRACT

Der p 23, a new, major house dust mite (HDM) allergen that is recognized by >70% of HDM-allergic patients, has high allergenic activity and, therefore, must be considered an important component for HDM-specific immunotherapy. We constructed and characterized a hypoallergenic Der p 23 vaccine for HDM immunotherapy. Three nonallergenic peptides from the C-terminal IgE epitope-containing part of Der p 23 (P4, P5) and P6, a mutant peptide containing serines instead of cysteines, were identified. Peptides were fused to the hepatitis B virus-derived PreS domain as recombinant fusion proteins (i.e., PreS-2XP4P5 and PreS-4XP6) that were expressed in Escherichia coli and purified to homogeneity. Compared with Der p 23, PreS-2XP4P5 and PreS-4XP6 showed no relevant IgE reactivity and exhibited considerably reduced allergenic activity in basophil activation tests using blood from HDM-allergic patients. Upon immunization of rabbits, only PreS-2XP4P5 induced high levels of Der p 23-specific IgG Abs that inhibited binding of patients' IgE to Der p 23, comparable to IgG Abs induced with Der p 23, whereas Abs induced with PreS-4XP6 had only low blocking capacity. Additionally, IgG Abs induced with PreS-2XP4P5 inhibited Der p 23-induced basophil activation comparable to IgG Abs induced with Der p 23. Compared with Der p 23, PreS-2XP4P5 induced lower T cell proliferation but higher levels of the tolerogenic cytokine IL-10 and the Th1 cytokine IFN-γ in PBMCs from HDM-allergic patients, indicating an immunomodulatory capacity of the fusion protein. Therefore, PreS-2XP4P5 represents a promising candidate for immunotherapy of HDM-allergic patients.


Subject(s)
Allergens/pharmacology , Antigens, Dermatophagoides/pharmacology , Basophils/immunology , Pyroglyphidae/immunology , Vaccines/pharmacology , Allergens/genetics , Allergens/immunology , Allergens/isolation & purification , Animals , Antigens, Dermatophagoides/genetics , Antigens, Dermatophagoides/immunology , Antigens, Dermatophagoides/isolation & purification , Basophils/pathology , Cell Proliferation/drug effects , Female , Humans , Immunoglobulin E/immunology , Interferon-gamma/immunology , Interleukin-10/immunology , Male , Rabbits , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Recombinant Proteins/isolation & purification , Recombinant Proteins/pharmacology , Th1 Cells/immunology , Vaccines/genetics , Vaccines/immunology , Vaccines/isolation & purification
5.
Methods ; 66(1): 106-19, 2014 Mar 01.
Article in English | MEDLINE | ID: mdl-24161540

ABSTRACT

Allergy diagnosis based on purified allergen molecules provides detailed information regarding the individual sensitization profile of allergic patients, allows monitoring of the development of allergic disease and of the effect of therapies on the immune response to individual allergen molecules. Allergen microarrays contain a large variety of allergen molecules and thus allow the simultaneous detection of allergic patients' antibody reactivity profiles towards each of the allergen molecules with only minute amounts of serum. In this article we summarize recent progress in the field of allergen microarray technology and introduce the MeDALL allergen-chip which has been developed for the specific and sensitive monitoring of IgE and IgG reactivity profiles towards more than 170 allergen molecules in sera collected in European birth cohorts. MeDALL is a European research program in which allergen microarray technology is used for the monitoring of the development of allergic disease in childhood, to draw a geographic map of the recognition of clinically relevant allergens in different populations and to establish reactivity profiles which are associated with and predict certain disease manifestations. We describe technical advances of the MeDALL allergen-chip regarding specificity, sensitivity and its ability to deliver test results which are close to in vivo reactivity. In addition, the usefulness and numerous advantages of allergen microarrays for allergy research, refined allergy diagnosis, monitoring of disease, of the effects of therapies, for improving the prescription of specific immunotherapy and for prevention are discussed.


Subject(s)
Allergens/immunology , Hypersensitivity/diagnosis , Protein Array Analysis , Adolescent , Animals , Calibration , Child , Child, Preschool , Humans , Hypersensitivity/immunology , Hypersensitivity/therapy , Immunoglobulin E/blood , Immunoglobulin G/blood , Immunotherapy , Quality Improvement , Recombinant Proteins/immunology , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...